INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation

BIT:1ISRG • US46120E6023

Current stock price

398 EUR
-10.8 (-2.64%)
Last:

This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1ISRG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • 1ISRG had a positive operating cash flow in the past year.
  • 1ISRG had positive earnings in each of the past 5 years.
  • 1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • 1ISRG has a Return On Assets of 13.96%. This is amongst the best in the industry. 1ISRG outperforms 96.83% of its industry peers.
  • The Return On Equity of 1ISRG (16.02%) is better than 87.30% of its industry peers.
  • 1ISRG's Return On Invested Capital of 13.95% is amongst the best of the industry. 1ISRG outperforms 92.06% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is above the industry average of 10.21%.
  • The last Return On Invested Capital (13.95%) for 1ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1ISRG has a Profit Margin of 28.38%. This is amongst the best in the industry. 1ISRG outperforms 100.00% of its industry peers.
  • 1ISRG's Profit Margin has improved in the last couple of years.
  • 1ISRG has a better Operating Margin (29.35%) than 98.41% of its industry peers.
  • In the last couple of years the Operating Margin of 1ISRG has grown nicely.
  • Looking at the Gross Margin, with a value of 66.00%, 1ISRG is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
  • 1ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1ISRG.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
  • 1ISRG has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ISRG has an Altman-Z score of 39.00. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 39.00, 1ISRG belongs to the top of the industry, outperforming 98.41% of the companies in the same industry.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 39
ROIC/WACC1.55
WACC8.99%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.87, 1ISRG belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
  • A Quick Ratio of 3.96 indicates that 1ISRG has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.96, 1ISRG belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1ISRG.MI Growth Analysis

3.1 Past

  • 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • Measured over the past years, 1ISRG shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.42% on average per year.
  • The Revenue has grown by 20.51% in the past year. This is a very strong growth!
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.58% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.90% on average over the next years. This is quite good.
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue Next Year15.83%
Revenue Next 2Y14.84%
Revenue Next 3Y14.56%
Revenue Next 5Y12.9%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ISRG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 51.35, the valuation of 1ISRG can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 61.90% of the companies listed in the same industry.
  • 1ISRG is valuated expensively when we compare the Price/Earnings ratio to 26.17, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 44.88, 1ISRG can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.05, 1ISRG is valued quite expensively.
Industry RankSector Rank
PE 51.35
Fwd PE 44.88
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 63.49% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
Industry RankSector Rank
P/FCF 65.41
EV/EBITDA 42.47
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.52% in the coming years.
PEG (NY)3.55
PEG (5Y)2.4
EPS Next 2Y14.34%
EPS Next 3Y14.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ISRG.MI Dividend Analysis

5.1 Amount

  • 1ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

BIT:1ISRG (3/30/2026, 7:00:00 PM)

398

-10.8 (-2.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-21
Inst Owners88.53%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap141.36B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts79.02
Price Target539.67 (35.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)1.07%
PT rev (3m)3.53%
EPS NQ rev (1m)0.05%
EPS NQ rev (3m)0.35%
EPS NY rev (1m)0%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 51.35
Fwd PE 44.88
P/S 16.19
P/FCF 65.41
P/OCF 53.76
P/B 9.14
P/tB 9.34
EV/EBITDA 42.47
EPS(TTM)7.75
EY1.95%
EPS(NY)8.87
Fwd EY2.23%
FCF(TTM)6.08
FCFY1.53%
OCF(TTM)7.4
OCFY1.86%
SpS24.59
BVpS43.54
TBVpS42.6
PEG (NY)3.55
PEG (5Y)2.4
Graham Number87.14
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 39
F-Score8
WACC8.99%
ROIC/WACC1.55
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.83%
Revenue Next 2Y14.84%
Revenue Next 3Y14.56%
Revenue Next 5Y12.9%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.56%
EBIT Next 3Y21.57%
EBIT Next 5Y17.26%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


What is the profitability of 1ISRG stock?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.


What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?

The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 14.45% in the next year.